Hemochromatosis is a condition in which too much iron builds up in the body. When people inherit the condition via their genes, it can be heterozygous or homozygous. “Heterozygous” means the person ...

The dosage of Praluent for pediatric patients aged 8 years and older with HeFH is based on body weight and can be adjusted based on LDL-C lowering response. The Food and Drug Administration (FDA) has ...

Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH). Eliot Brinton, MD: I’m Dr Elliot Brinton. I’m the president ...

A University of Georgia study reveals that genetic factors influence how fish oil supplements affect omega-3 levels in the ...

Heterozygous familial hypercholesterolemia (HeFH) is a monogenic disorder that affects about 1 in 500 people, with a higher prevalence in certain subpopulations such as people of Quebecois, Christian ...

Patients with familial hypercholesterolemia (FH) often are diagnosed late in life and remain undertreated with lipid-lowering medications despite their increased risk for cardiovascular disease, ...

Homozygous, or homozygosity, refers to the inheritance of genes from each biological parent. Inheriting faulty genes from both parents can cause a person to develop the associated condition. Genetic ...

In general, humans have the same genes. A number of genes are varied. These control our physical traits and health. Each variation is called an allele. You inherit two alleles for each gene. One comes ...

Ezetimibe (Ezetrol) on its own is recommended as a possible treatment for adults with primary (heterozygous‑familial or non‑familial) hypercholesterolaemia who cannot start statin therapy because: If ...